Curium, a world leader in nuclear medicine, announced today that it has expanded its existing partnership with Institute of ...

The condom will reduce the risk of contamination, but will not shield from the I-131 gamma radiation. In most cases, this is the most important safety issue. Once excretion is effectively complete, ...

Ltd. (Izotop) to make Iodine-131 diagnostic capsules available to patients in the Nordic Region and in other European countries later in 2025, with regulatory approval processes in progress.

About Cellectar Biosciences, Inc. Cellectar Biosciences is a late-stage clinical biopharmaceutical company focused on the discovery and development of proprietary drugs for the treatment of cancer, ...

Radionuclide therapy is changing dynamically. Monoclonal antibody therapies for non-Hodgkins lymphoma using iodine-131; or imaging with indium-111, followed with yttrium-90 for the therapy are the ...

In addition to being a diagnostic tool, they are also used therapeutically in the treatment of cancer; radioactive iodine-131 has been used to treat thyroid cancer for more than 50 years.